COPD prevalence among HLA-C*07 + HLA-C*12 heterozygotes (46%) tended to be intermediate between subjects with only HLA-C*07 (62%) or only HLA-C*12 (35%), but the difference did not reach significance (P = 0.1). This evidence concerns the gene HLA-C and chronic obstructive pulmonary disease.